Putney

Putney is a pharmaceutical company dedicated to developing and commercializing generic prescription medicines for the veterinary market. The company focuses on providing high-quality, FDA-approved alternatives to costly brand-name pet medications, primarily for dogs and cats. Its product portfolio includes treatments for pain management, anti-infectives, and other common veterinary conditions. Founded in 2006 and headquartered in Portland, Maine, Putney was a pioneer in the veterinary generic space before its acquisition by Dechra Pharmaceuticals in 2016. The company's mission centers on making pet healthcare more affordable for owners while maintaining rigorous regulatory standards.